Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | GLA | P06280 | 3/20 | 0.38 |
| ▸ | DHODH | Q02127 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 2/20 | 0.38 |
| ▸ | CASP7 | P55210 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3665178 | 0.80 | DHODH (0.43) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| SCHEMBL8521020 | 0.80 | MAOA (0.56) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| SCHEMBL10527277 | 0.77 | MAOA (0.47) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| SCHEMBL5388884 | 0.74 | ALDH1A1 (0.57) | MAOAMAOBKDM4EALDH1A1DHODH | |
| Acridone SCHEMBL243819 | 0.74 | KDM4E (0.56) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| SCHEMBL10527280 | 0.73 | MAOA (0.57) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| SCHEMBL1758027 | 0.73 | MAOA (0.57) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| SCHEMBL525342 | 0.73 | MAOA (0.52) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| Acridone SCHEMBL5719993 | 0.72 | KDM4E (0.54) | MAOAMAOBKDM4EALDH1A1TDP1 | |
| Acridone SCHEMBL345058 | 0.72 | ALDH1A1 (0.54) | MAOAMAOBKDM4EALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102274347-A | Anticancer composition and application thereof | — | 2011-12-14 | — | — | CN | claimed |
| US-4485091-A | HYDROGEN PEROXIDE, OIL IN WATER EMULSION | QUINODERM LIMITED (GB) | 1984-11-27 | — | — | US | claimed |
| US-20230405025-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | Max Biology Co. Ltd. (KH) | 2023-12-21 | — | — | US | disclosed |
| EP-4225298-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | MAX BIOLOGY CO. LTD. (KH) | 2023-08-16 | — | — | EP | disclosed |
| US-20200345806-A1 | METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATON | UNITED AH II LLC (US) | 2020-11-05 | — | — | US | disclosed |
| US-10668127-B2 | Method and composition for synchronizing time of insemination | UNITED-AH II, LLC (US) | 2020-06-02 | — | — | US | disclosed |
| EP-2925339-B1 | METHOD FOR SYNCHRONIZING TIME OF INSEMINATION IN GILTS | UNITED AH II LLC (US) | 2020-04-29 | — | — | EP | disclosed |
| US-10376558-B2 | Method and compositions for synchronizing time of insemination in gilts | UNITED-AH II, LLC (US) | 2019-08-13 | — | — | US | disclosed |
| US-10286031-B2 | Method of manufacture of GnRH-containing gel | UNITED-AH II, LLC (US) | 2019-05-14 | — | — | US | disclosed |
| EP-3131567-B1 | METHOD OF MANUFACTURE OF GNRH-CONTAINING GEL | UNITED AH II LLC (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20180133283-A1 | METHOD AND COMPOSITIONS FOR SYNCHRONIZING TIME OF INSEMINATION IN GILTS | JBS UNITED ANIMAL HEALTH II LLC (US) | 2018-05-17 | — | — | US | disclosed |
| US-5840744-A | Intravaginal treatment of vaginal infections with buffered metronidazole compositions | MINNESOTA MINING AND MANUFACTURING CO. (US) | 1998-11-24 | — | — | US | disclosed |
| US-5536743-A | Intravaginal treatment of vaginal infections with buffered metronidazole compositions | CURATEK PHARMACEUTICALS LIMITED PARTNERSHIP (US) | 1996-07-16 | — | — | US | disclosed |
| EP-0404376-B1 | Buffered metronidazole compositions for intravaginal treatment of vaginal infections | CURATEK PHARMACEUTICALS (US) | 1994-03-23 | — | — | EP | disclosed |
| EP-0404376-A2 | Buffered metronidazole compositions for intravaginal treatment of vaginal infections | CURATEK PHARMACEUTICALS Limited Partnership (US) | 1990-12-27 | — | — | EP | disclosed |
| WO-1990014832-A1 | IMPROVED INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH BUFFERED METRONIDAZOLE COMPOSITIONS | CURATEK PHARMACEUTICALS LIMITED PARTNERSHIP (US) | 1990-12-13 | — | — | WO | disclosed |
| US-4668517-A | GASTROINTESTINAL DISORDERS, DIARRHEA | NORWICH EATON PHARMACEUTICALS, INC. (US) | 1987-05-26 | — | — | US | disclosed |
| EP-0137212-A2 | Ointment bases and ointments | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-04-17 | — | — | EP | disclosed |
| US-4485091-A | HYDROGEN PEROXIDE, OIL IN WATER EMULSION | QUINODERM LIMITED (GB) | 1984-11-27 | — | — | US | disclosed |
| US-4017615-A | ESPECIALLY USEFUL FOR ANTIINFLAMMATORY TOPICAL CORTICOIDS | SYNTEX CORPORATION (PM) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10286031-B2 | Method of manufacture of GnRH-containing gel | GNRHR, SHBG, LPXN | MAOA 911/4885MAOB 1111/4885KDM4E 1275/4885 |
| US-10376558-B2 | Method and compositions for synchronizing time of insemination in gilts | GNRHR, LHCGR, PIGS | MAOA 3739/4885MAOB 3615/4885KDM4E 4723/4885 |
| US-20180133283-A1 | METHOD AND COMPOSITIONS FOR SYNCHRONIZING TIME OF INSEMINATION IN GILTS | GNRHR, LHCGR, PIGS | MAOA 3739/4885MAOB 3615/4885KDM4E 4723/4885 |
| US-20230405025-A1 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | CNR2, CNR1, FAAH | MAOA 3306/4885MAOB 3685/4885KDM4E 1565/4885 |
| US-20200345806-A1 | METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATON | SHBG, PIGS, NR5A1 | MAOA 2958/4885MAOB 2174/4885KDM4E 4834/4885 |
| US-10668127-B2 | Method and composition for synchronizing time of insemination | SHBG, PIGS, NR5A1 | MAOA 2792/4885MAOB 2932/4885KDM4E 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.